Stelara (ustekinumab) 130 mg concentrate for solution for infusion, 1 vial — original (Cilag AG, Switzerland) Plaque psoriasis Delivery of medications from Europe and beyond within 4-5 days, storage conditions are met, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.
45 mg - $700
90 mg - $1250
Display
Blyashkovy psoriasis
Treatment of plaque psoriasis from mild to severe stage in adults who have not had a positive effect of treatment or may have contraindications or intolerance to other aspects of systemic therapy, including cyclosporine, methotrexate or PUVA therapy.
Plaque psoriasis in children
Treatment of plaque psoriasis from mild to severe stage in children over 12 years of age, which is not sufficiently controlled other methods of systemic therapy, either phototherapy, or in case of intolerance to such therapy.
Psoriatic arthritis
Like monotherapy or a combination with methotrexate for the treatment of active psoriatic arthritis in adults, which has no small positive effect when treated with basic anti-rheumatic drugs that modify the disease illness (DMARD).
Dozuvannya
Plaque psoriasis.
Administer cob dose 45 mg, the next dose of 45 mg should be administered after 4 days on the scalp, then on the skin 12 days.
It is necessary to re-examine the nutritional value of continuing therapy for patients who have a daily therapeutic effect up to the 28th day of treatment.
Patients with body weight over 100 kg.
Patients with a body weight of more than 100 kg are prescribed an initial dose of 90 mg, then a dose of 90 mg is administered after 4 Tizhnі, then – skin 12 tizhnі. For this group of patients, a dose of 45 mg may also be effective, but a dose of 90 mg will provide greater effectiveness.
Psoriatic arthritis.
Administer a dose of 45 mg per ear, then administer a dose of 45 mg every 4 days, then every 12 days. For patients with a body weight greater than 100 kg, the daily dose may be 90 mg.
It is necessary to re-examine the nutritional value of continuing therapy for patients who have a daily therapeutic effect up to the 28th day of treatment.
- Trade Name:STELARA
- Chemical Name:ustekinumab
- Dosage:130 mg
- Quantity:1
- Form of Issue:Flacon